Dose-dense epirubicin and cyclophosphamide followed by docetaxel as adjuvant chemotherapy in node-positive breast cancer
about
Dose-dense epirubicin and cyclophosphamide followed by weekly Paclitaxel in node-positive breast cancerKnockdown of UbcH10 enhances the chemosensitivity of dual drug resistant breast cancer cells to epirubicin and docetaxel.Randomised phase III trial of FEC120 vs EC-docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR study.
P2860
Dose-dense epirubicin and cyclophosphamide followed by docetaxel as adjuvant chemotherapy in node-positive breast cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dose-dense epirubicin and cycl ...... in node-positive breast cancer
@en
Dose-dense epirubicin and cycl ...... n node-positive breast cancer.
@nl
type
label
Dose-dense epirubicin and cycl ...... in node-positive breast cancer
@en
Dose-dense epirubicin and cycl ...... n node-positive breast cancer.
@nl
prefLabel
Dose-dense epirubicin and cycl ...... in node-positive breast cancer
@en
Dose-dense epirubicin and cycl ...... n node-positive breast cancer.
@nl
P2093
P2860
P356
P1476
Dose-dense epirubicin and cycl ...... in node-positive breast cancer
@en
P2093
Fatemeh Nasrollahi
Hamid Reza Mirzaei
Hamid Reza Moein
Parastoo Hajian
Parisa Sabet Rasekh
Parto Sabet Rasekh
Taban Ghaffari Pour
Zahra Akbari Tirabad
P2860
P304
P356
10.1155/2013/404396
P577
2013-09-25T00:00:00Z